类风湿关节炎患者自身抗体与静脉血栓栓塞事件风险的相关性
研究纳入2814例新诊断类风湿关节炎患者,随访中位16年,记录到213例首次静脉血栓栓塞事件。基线IgG抗CCP2、ACPA精细特异性负荷及IgM类风湿因子与未来静脉血栓栓塞风险相关,而抗氨甲酰化和乙酰化抗体与静脉血栓栓塞无关。
要点
- 中位随访16年,213例首次静脉血栓栓塞事件,发生率5.0/1000人年。
- 基线IgG抗CCP2阳性与静脉血栓栓塞风险相关,呈剂量反应关系。
- 静脉血栓栓塞风险随ACPA精细特异性数量增加而升高,IgM类风湿因子亦相关。
核心结论
- 基线抗CCP2、ACPA精细特异性负荷及IgM类风湿因子与类风湿关节炎患者未来静脉血栓栓塞风险升高相关。
- 抗瓜氨酸化纤维蛋白原抗体与其他ACPA精细特异性无实质差异,其他翻译后修饰自身抗体与静脉血栓栓塞风险无关。
研究设计与样本
- 队列研究,纳入2814例新诊断类风湿关节炎患者,通过登记链接随访静脉血栓栓塞事件。
- 基线血清集中检测抗CCP2、20种ACPA精细特异性、抗氨甲酰化和乙酰化抗体及类风湿因子同种型。
- 采用Cox回归分析基线血清学状态与未来静脉血栓栓塞的关联,校正年龄、性别和类风湿关节炎诊断日历年。
主要发现
- 中位随访16年,登记213例首次静脉血栓栓塞事件,发生率5.0/1000人年。
- IgG抗CCP2阳性见于65%队列,与静脉血栓栓塞相关(HR=1.33,95%CI:1.00,1.78),呈剂量反应关系。
- 静脉血栓栓塞风险随ACPA精细特异性数量增加而升高。
- IgM类风湿因子与静脉血栓栓塞相关(HR=1.38,95%CI:1.04,1.82),其他类风湿因子同种型无关联。
- 抗氨甲酰化或乙酰化抗体反应性与静脉血栓栓塞均无关,关联独立于吸烟和HLA-DRB1共享表位等位基因。
关键数值与推荐
- IgG抗CCP2阳性率65%,与静脉血栓栓塞的HR=1.33(95%CI:1.00,1.78)。
- IgM类风湿因子与静脉血栓栓塞的HR=1.38(95%CI:1.04,1.82)。
- 静脉血栓栓塞发生率5.0/1000人年,中位随访16年,首次事件213例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the association between venous thromboembolic (VTE) events and autoantibodies, following patients from RA diagnosis, measuring occurrence, levels and collective load of different autoantibodies against post-translational protein modifications, in particular recognizing citrullination (e.g. citrullinated fibrinogen) and RF by isotype. METHODS: A cohort of 2814 patients with newly diagnosed RA were followed for incident VTE through register linkages. Sera from RA diagnosis were centrally analysed for antibodies to second generation cyclic citrullinated peptides (anti-CCP2), 20 anti-citrullinated protein antibody (ACPA) fine-specificities, antibodies to additional protein modifications (carbamylation and acetylation) and RF by isotype. Association between baseline serology status and future VTE was analysed using Cox regression adjusted for age, sex and calendar period of RA diagnosis, overall and stratified by anti-CCP2 and RF positivity. RESULTS: During a median 16 years of follow-up, 213 first-ever VTE events were registered (5.0/1000 person-years). IgG anti-CCP2 (present in 65% of cohort) associated with VTE (hazard ratio [HR] = 1.33, 95% CI: 1.00, 1.78), in a dose-response manner. The risk of VTE increased with number of ACPA fine-specificities. IgM RF, but no other RF isotypes, associated with VTE (HR = 1.38, 95% CI: 1.04, 1.82). The associations were independent from smoking and HLA-DRB1 shared epitope alleles. None of the carbamylated or acetylated antibody reactivities associated with VTE. CONCLUSION: Anti-CCP2, load of ACPA fine-specificities and IgM RF at RA diagnosis are associated with an increased risk of future VTE in RA. Antibodies to citrullinated fibrinogen did not differ substantially from other ACPA fine-specificities. Autoreactivity to other post-translational modifications was not associated with VTE risk.
引用
- Westerlind H, Kastbom A, Rönnelid J, et al. The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis. Rheumatology (Oxford). 2023. PMID: 36255271. doi:10.1093/rheumatology/keac601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。